| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Toshiyuki Yamamoto | |
| P2860 | cites work | IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats | Q24294661 |
| Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy | Q24804272 | ||
| Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis | Q24816628 | ||
| Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis | Q27693878 | ||
| Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions appear antigen driven | Q28143006 | ||
| Bone morphogenetic proteins | Q28300236 | ||
| Psoriatic arthritis: a unified concept twenty years on. | Q33656096 | ||
| Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor | Q33659004 | ||
| The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy | Q34016674 | ||
| Psoriatic arthritis--what the dermatologist needs to know. | Q34109672 | ||
| Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. | Q34637966 | ||
| Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study | Q34700921 | ||
| High-resolution MRI assessment of dactylitis in psoriatic arthritis shows flexor tendon pulley and sheath-related enthesitis | Q34818578 | ||
| Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis | Q34967810 | ||
| T cell derived cytokines in psoriatic arthritis synovial fluids | Q35547611 | ||
| Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis | Q35550259 | ||
| Dactylitis in psoriatic arthritis: a marker for disease severity? | Q35555241 | ||
| The challenge of early diagnosis of psoriatic arthritis | Q80448847 | ||
| Environmental risk factors for the development of psoriatic arthritis: results from a case-control study | Q81152552 | ||
| Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial | Q81300604 | ||
| Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT) | Q81629371 | ||
| IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis | Q83163682 | ||
| Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis | Q83330824 | ||
| Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis | Q85036491 | ||
| Psoriatic arthritis | Q93745377 | ||
| Role of trauma in psoriatic arthritis | Q95818446 | ||
| Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment | Q35638455 | ||
| Immunopathology of psoriasis and psoriatic arthritis | Q36040037 | ||
| The concept of a "synovio-entheseal complex" and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond | Q36897200 | ||
| Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling. | Q37091516 | ||
| The pathobiology of psoriatic synovium | Q37182472 | ||
| Treatment recommendations for psoriatic arthritis. | Q37284516 | ||
| The nail as a musculoskeletal appendage--implications for an improved understanding of the link between psoriasis and arthritis | Q37342491 | ||
| The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all? | Q37474290 | ||
| Psoriatic arthritis: a dermatologist's perspective | Q37768404 | ||
| Psoriatic arthritis: from a dermatological perspective | Q37895780 | ||
| Management of psoriatic arthritis from the view of the dermatologist | Q37930978 | ||
| Altered bone biology in psoriatic arthritis | Q38010645 | ||
| Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review. | Q38225380 | ||
| Cellular sources of IL-17 in psoriasis: a paradigm shift? | Q38231403 | ||
| Comprehensive treatment of dactylitis in psoriatic arthritis | Q38264284 | ||
| Optimisation of rheumatology indices: dactylitis and enthesitis in psoriatic arthritis | Q38264517 | ||
| New developments in our understanding of psoriatic arthritis and their impact on the diagnosis and clinical management of the disease | Q39373505 | ||
| Development of an assessment tool for dactylitis in patients with psoriatic arthritis | Q39729055 | ||
| Angiogenic and inflammatory properties of psoriatic arthritis | Q42156810 | ||
| Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis | Q43049870 | ||
| Interleukin 13 in synovial fluid and serum of patients with psoriatic arthritis | Q43051359 | ||
| Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey | Q43464060 | ||
| Prevalence and clinical characteristics of dactylitis in spondylarthritis: a descriptive analysis of 275 patients | Q44185652 | ||
| The diagnostic and therapeutic challenge of early psoriatic arthritis. | Q44305067 | ||
| Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies | Q45334739 | ||
| IL-17 receptor and its functional significance in psoriatic arthritis. | Q45983163 | ||
| IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells | Q46043893 | ||
| Dactylitis in psoriatic arthritis: prevalence and response to therapy in the biologic era. | Q46415476 | ||
| Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial | Q46467386 | ||
| Clinical analysis of 21 patients with psoriasis arthropathy | Q46500742 | ||
| Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial | Q46585904 | ||
| Nail psoriasis in Germany: epidemiology and burden of disease | Q48818632 | ||
| IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-kappaB (RANK) expression in myeloid precursor cells. | Q50771304 | ||
| Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. | Q50906224 | ||
| Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. | Q52844455 | ||
| Angiopoietins, growth factors, and vascular morphology in early arthritis. | Q52860641 | ||
| Psoriatic arthritis. | Q53114860 | ||
| Epidemiology of psoriatic arthritis in the population of the United States. | Q53276933 | ||
| Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α | Q59074915 | ||
| Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFα, and IL-7 in anin vitromodel derived from human psoriatic arthritis | Q61043823 | ||
| Early Psoriatic Arthritis | Q61824587 | ||
| Psoriatic arthritis. New types, new treatments | Q71077329 | ||
| Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease | Q72177619 | ||
| Classification of clinical subsets in psoriatic arthritis | Q72373702 | ||
| Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid | Q73128367 | ||
| Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid | Q74151287 | ||
| Clinical and genetic aspects of psoriatic arthritis "sine psoriasis" | Q75248220 | ||
| Predominance of CD8+ T lymphocytes in psoriatic arthritis | Q77762643 | ||
| Psoriatic arthritis | Q77803164 | ||
| A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience | Q79108013 | ||
| Dickkopf-1 is a master regulator of joint remodeling | Q79610564 | ||
| Classification criteria for psoriatic arthritis: development of new criteria from a large international study | Q80001900 | ||
| Dactylitis or "sausage-shaped" digit | Q80435886 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | psoriatic arthritis | Q511097 |
| Dactylitis | Q517782 | ||
| P304 | page(s) | 55-62 | |
| P577 | publication date | 2015-09-18 | |
| P1433 | published in | Open Access Rheumatology: Research and Reviews | Q15816468 |
| P1476 | title | Optimal management of dactylitis in patients with psoriatic arthritis | |
| P478 | volume | 7 |
| Q57456661 | Efficacy of new treatments for dactylitis of psoriatic arthritis: update of literature review | cites work | P2860 |
Search more.